A detailed history of Veriti Management LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Veriti Management LLC holds 26,847 shares of RPRX stock, worth $651,845. This represents 0.04% of its overall portfolio holdings.

Number of Shares
26,847
Previous 19,030 41.08%
Holding current value
$651,845
Previous $501,000 51.5%
% of portfolio
0.04%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$25.63 - $29.27 $200,349 - $228,803
7,817 Added 41.08%
26,847 $759,000
Q2 2024

Aug 02, 2024

SELL
$26.26 - $29.9 $68,774 - $78,308
-2,619 Reduced 12.1%
19,030 $501,000
Q1 2024

Apr 19, 2024

BUY
$27.46 - $31.33 $2,855 - $3,258
104 Added 0.48%
21,649 $657,000
Q4 2023

Feb 05, 2024

BUY
$26.21 - $29.22 $144,181 - $160,739
5,501 Added 34.29%
21,545 $605,000
Q3 2023

Oct 27, 2023

BUY
$26.26 - $31.38 $421,315 - $503,460
16,044 New
16,044 $435,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.